2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide

C33H40N6O — CID 162668578

IUPAC2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide
SMILESO=C(NCCCN1CCCC1)c1ccnc(-c2ccccc2N2CCN(CCc3c[nH]c4ccccc34)CC2)c1
InChIInChI=1S/C33H40N6O/c40-33(35-14-7-18-37-16-5-6-17-37)26-12-15-34-31(24-26)29-9-2-4-11-32(29)39-22-20-38(21-23-39)19-13-27-25-36-30-10-3-1-8-28(27)30/h1-4,8-12,15,24-25,36H,5-7,13-14,16-23H2,(H,35,40)
InChIKeyZRGMZIXVBWLLHA-UHFFFAOYSA-N
MW536.72 g/mol
LogP4.81
Rot. Bonds10

About 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide

2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide (PubChem CID 162668578) has the molecular formula C33H40N6O and a molecular weight of 536.72 g/mol. Its IUPAC name is 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide.

Molecular Properties

Compound Name2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide
PubChem CID162668578
Molecular FormulaC33H40N6O
Molecular Weight536.72 g/mol
Exact Mass536.33
IUPAC Name2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide
SMILESO=C(NCCCN1CCCC1)c1ccnc(-c2ccccc2N2CCN(CCc3c[nH]c4ccccc34)CC2)c1
InChIInChI=1S/C33H40N6O/c40-33(35-14-7-18-37-16-5-6-17-37)26-12-15-34-31(24-26)29-9-2-4-11-32(29)39-22-20-38(21-23-39)19-13-27-25-36-30-10-3-1-8-28(27)30/h1-4,8-12,15,24-25,36H,5-7,13-14,16-23H2,(H,35,40)
InChIKeyZRGMZIXVBWLLHA-UHFFFAOYSA-N
XLogP4.81
TPSA67.50 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds10
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500536.72
LogP ≤ 54.81
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide?
The IUPAC name of 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide (CID 162668578) is 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide.
What is the SMILES notation for 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide?
The canonical SMILES for 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide is O=C(NCCCN1CCCC1)c1ccnc(-c2ccccc2N2CCN(CCc3c[nH]c4ccccc34)CC2)c1.
What is the InChIKey of 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide?
The InChIKey is ZRGMZIXVBWLLHA-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H40N6O/c40-33(35-14-7-18-37-16-5-6-17-37)26-12-15-34-31(24-26)29-9-2-4-11-32(29)39-22-20-38(21-23-39)19-13-27-25-36-30-10-3-1-8-28(27)30/h1-4,8-12,15,24-25,36H,5-7,13-14,16-23H2,(H,35,40).
What are the key properties of 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide?
2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide has a molecular weight of 536.72 g/mol, XLogP of 4.81, 10 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[4-[2-(1H-indol-3-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)pyridine-4-carboxamide is sourced from PubChem (CID 162668578), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).